Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by a mutation in either of the two tumor suppressor genes, TSC1 and TSC2. Due to dysregulated activity of the mammalian target of rapamycin (mTOR) pathway, hamartomas or benign tumors frequently occur in many organs and are of...
Saved in:
Main Authors: | Konomi Shimoda (Author), Hiroyuki Iwasaki (Author), Yoko Mizuno (Author), Masafumi Seki (Author), Masakazu Mimaki (Author), Motohiro Kato (Author), Aya Shinozaki-Ushiku (Author), Harushi Mori (Author), Seishi Ogawa (Author), Masashi Mizuguchi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inverse Agonistic Activity of Antihistamines and Suppression of Histamine H1 Receptor Gene Expression
by: Hiroyuki Mizuguchi, et al.
Published: (2012) -
Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNA
by: Mitsuhiro Machitani, et al.
Published: (2017) -
Lymphangiomatosis With Hemihypertrophy
by: James A. Waler MD, et al.
Published: (2016) -
ISOLATED HEMIHYPERTROPHY IN CHILD
by: Lorena Elena Melit, et al.
Published: (2016) -
Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex
by: Dong-Dong Wang, et al.
Published: (2020)